Omer S Karrar

11PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 16, 2026
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.

|May 27, 2026
Long-term outcomes of azacitidine, venetoclax, and gilteritinib in newly diagnosed FLT3-mutated AML.

|Feb 06, 2026
Prospective feasibility study of peripheral blood for MRD detection in acute myeloid leukemia by flow cytometry.

Shaoying Li, Nicholas J Short, Wei Wang

|Aug 09, 2025
Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase.

Omer Karrar, Hagop Kantarjian, Fadi G Haddad

|Jan 18, 2024
One thousand patients with essential thrombocythemia: the Mayo Clinic experience.

Naseema Gangat, Omer Karrar, Aref Al-Kali

|Dec 15, 2023
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

Omer Karrar, Maymona Abdelmagid, Masooma Rana

Pageof 2

Frequent Collaborators

6 joint publications

Nicholas J Short

4 joint publications

Naseema Gangat

4 joint publications

Aref Al-Kali

4 joint publications

Kebede H Begna